27-07-2021, 10:53 AM
By Josh Nathan-Kazis
Updated July 26, 2021 9:44 pm ET / Original July 26, 2021 8:22 am ET
Order Reprints
Print Article
The protection provided by Pfizer and BioNTech’s Covid-19 vaccine is dropping due to the Delta variant, BioNTech’s CEO told The Wall Street Journal in an interview published Sunday, but most recipients are still protected against severe disease caused by the virus.
“The vaccine protection against the new variant is considerably lower,” BioNTech (ticker: BNTX) CEO Dr. Ugur Sahin told the Journal.
https://www.barrons.com/articles/biontec...1627302003
Updated July 26, 2021 9:44 pm ET / Original July 26, 2021 8:22 am ET
Order Reprints
Print Article
The protection provided by Pfizer and BioNTech’s Covid-19 vaccine is dropping due to the Delta variant, BioNTech’s CEO told The Wall Street Journal in an interview published Sunday, but most recipients are still protected against severe disease caused by the virus.
“The vaccine protection against the new variant is considerably lower,” BioNTech (ticker: BNTX) CEO Dr. Ugur Sahin told the Journal.
https://www.barrons.com/articles/biontec...1627302003